Specifications - AstraZeneca Pharmaceutical Manufacturing Plant,, China

Key Data
Order year	1998
Project type	East and North Asia
Location	Wuxi, outside Shanghai, China
Estimated investment	$134m, 2006 (new packaging line worth $3.8m)
Completion	2000
Key Players
Sponsor & Financing	AstraZeneca
Output Chemicals
Unknown	Various: Over 80% of the medicines sold by AstraZeneca in China are manufactured at Wuxi
Featured Suppliers
Pharmadule - Modular Pharmaceutical and Biopharmaceutical Production Facilities